Pharma Focus Asia
KP - Sustainable Packaging Solutions

AstraZeneca Invests US$1.05 billion (£1bn) to Construct New R&D Facility

Introduction:

AstraZeneca plans for the construction of state-of-the-art research and development (R&D) facility with an investment of US$1.05 billion (£1bn). The new discovery center will be located in Cambridge, UK.

Features:

The new R& D center will be designed with world’s highest environmental standards conataining over 2,200 research scientists.

State-of-the-art facility consists of most advanced robotics, with the high-throughput screening and AI-driven technology.The facility designed with advanced robots and technology will help to focus on specialised and precision medicinesgiving raise for the discovery of next generation therapeutics, including nucleotide-based, gene-editing and cell therapies.

The new Discovery Centre will manage the next wave of scientific innovation and thus enabling to break new boundaries in the understanding of disease biology and therby bringing life-changing medicines to patients.

The center will further help to develop the next generation of science leaders and helps in fastening industry-leading levels of productivity.

Specifications:

NameAstraZeneca
TypeNew Construction
BudgetUS$1.05 billion
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?